Treating Latent TB in the Elderly Poses Greater Risk

12 Jan 2011
by Working Group

Several news agencies reported on an article that appeared in the Canadian Medical Association Journal showing an increase risk of serious side-effects for patients over 65 years old being treated for latent tuberculosis. Compared to untreated patients matched by age, patients 65 years old being treated for latent TB had a 6 fold higher risk of being hospitalized for liver problems. The sample size was 9, 145 persons and historical data from administrative health data from Quebec, Canada, was analyzed. These researchers stressed “careful consideration of risks and benefits” for this population.

Additional Coverage:

Bloomberg Businessweek




More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...